302 related articles for article (PubMed ID: 12880)
21. Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients.
Koch G
Am Heart J; 1977 May; 93(5):585-91. PubMed ID: 851058
[TBL] [Abstract][Full Text] [Related]
22. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
Koch G
Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
[TBL] [Abstract][Full Text] [Related]
24. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
Weber MA; Drayer JI; Kaufman CA
J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
[TBL] [Abstract][Full Text] [Related]
25. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
Martinand A; Lardoux H; Corvol P; Milliez P
Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
[TBL] [Abstract][Full Text] [Related]
26. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic effect of trandat, an alpha- and beta-adrenergic receptor blockader, and its effect on central, regional and intracardiac hemodynamics].
Erina EV; Charyev KhE; Beliakova EV; Tverskaia LV; Kukharchuk VV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):68-74. PubMed ID: 6124260
[TBL] [Abstract][Full Text] [Related]
28. Comparison of labetalol with other anti-hypertensive drugs.
Prichard BN; Richards DA
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
[TBL] [Abstract][Full Text] [Related]
29. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
[TBL] [Abstract][Full Text] [Related]
30. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
Richards DA; Tuckman J; Prichard BN
Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
[TBL] [Abstract][Full Text] [Related]
31. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
Hansson L; Hänel B
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
[TBL] [Abstract][Full Text] [Related]
32. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
Riddell JG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular effects of labetalol during halothane anaesthesia.
Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
[TBL] [Abstract][Full Text] [Related]
34. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
35. Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade.
Lubbe WF; White DA
Clin Sci Mol Med Suppl; 1978 Dec; 4():283s-286s. PubMed ID: 32006
[TBL] [Abstract][Full Text] [Related]
36. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
Cherchi A; Raffo M; Sau F; Seguro C; Pirisi R
Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
[No Abstract] [Full Text] [Related]
37. Combined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagon.
Meretoja OA; Allonen H; Arola M; Laaksonen VO
Chest; 1980 Dec; 78(6):810-5. PubMed ID: 7004797
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological basis for antihypertensive effects of intravenous labetalol.
Richards DA; Prichard BN; Boakes AJ; Tuckman J; Knight EJ
Br Heart J; 1977 Jan; 39(1):99-106. PubMed ID: 12778
[TBL] [Abstract][Full Text] [Related]
39. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
40. Labetalol in essential hypertension.
Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]